Benlysta 120 mg and 400 mg powder for concentrate for solution for infusion

Company:
GlaxoSmithKline (Ireland) Ltd
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Belimumab
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/11/700/001-002

120 milligram(s)

L04AA,L04AA26

Powder for Solution for infusion